跳至主要内容
临床试验/JPRN-UMIN000002081
JPRN-UMIN000002081已完成2 期

preoperative combined chemothrapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer; multicentric phase II study - preoperative DCS therapy in local advanced gastric cancer

Society for the study of DCS therapy0 个研究点目标入组 55 人开始时间: 2009年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) obvious infection 2) severe complication 3) active other malignancies 4) distant metastases 5) motor palalysis or peripheral neuropathy 6) drug hypersensitivity 7) mental disorder 8) possibility of pregnancy 9) judged as unsuitable by the doctor in charge

研究者

发起方
Society for the study of DCS therapy

相似试验

已完成
不适用
Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.Breast cancer
JPRN-UMIN000002310Gunma Breast Cancer Research Group 2 surgery90
进行中(未招募)
1 期
eoadjuvant, sequential chemotherapy with docetaxel followed by Fluorouracil, Epirubicin, and Cyclophosphamid every 3 weeks - genome wide expression analysis for identification of a predictive gene signature in patients with primary breast cancer - EXPRESSIOEligible will be only females between 18 - 70 years of age, suffering from histologically confirmed primary breast cancer, nodal status positive or negative, phase cT2, cT3, or cT4 including inflammatory disease. Metastatic disease is excluded. All patients will be treated with 3 cycles Docetaxel and 3 cycles FEC.MedDRA version: 14.1Level: PTClassification code 10006201Term: Breast cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10021974Term: Inflammatory breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006200Term: Breast cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2008-006381-29-DEniversitätsmedizin Mainz200
已完成
不适用
Docetaxel plus cyclophophamide as adjuvant chemotherapy for negative axillary lymph node breast cancerBreast Cancer
JPRN-UMIN000001076Kinki Multidisciplinary Breast Oncology Group35
已完成
3 期
eoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response.Cancer - BreastBreast Cancer
ACTRN12605000588695Monash Health180
已完成
1 期
Combination of chemotherapy with docetaxel / cisplatin / fluorouracil (DCF) and autologous gamma/delta T cell transfer therapy for esophageal cancer.Esophageal cancer
JPRN-UMIN000008097The University of Tokyo Hospital20
preoperative combined chemothrapy with docetaxel,... | 临床试验